STOCK TITAN
  1. Home
  2. Sec-filings
  3. ENTO
  4. [SEC STAFF ACTION] Entero Therapeutics, Inc. SEC Filing

[SEC STAFF ACTION] Entero Therapeutics, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SEC STAFF ACTION

Rhea-AI Filing Summary

Analyzing...
SEC STAFF ACTION - Entero Therapeutics, Inc.

SEC STAFF ACTION Filing - Entero Therapeutics, Inc.

This filing is available as a PDF document.

Filing Type: SEC STAFF ACTION

Company: Entero Therapeutics, Inc. (ENTO)

Acceptance Date: 2025-09-26T10:00:03.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock ENTO logo
Entero Therapeutics

NASDAQ:ENTO

ENTO Rankings

#6330 Ranked by Market Cap
N/A Ranked by Dividends

ENTO Latest News

Nov 28, 2025
Entero Therapeutics, Inc. Announces Corporate Name Change to GridAI Technologies Corp. and New Ticker Symbol "GRDX"
Nov 19, 2025
ENTO Subsidiary Grid AI Announces Letter of Intent with First Hyperscaler AI Data-Center Customer
Nov 13, 2025
Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy
Nov 6, 2025
Entero Subsidiary Grid AI Accelerates Expansion into Hyperscaler AI Data Center Market with Integration of LV Grid
Oct 30, 2025
Entero's Reinvention Gives the Grid, AI, and Investors Exactly What They're After: Power and Value (NASDAQ: ENTO)

ENTO Latest SEC Filings

Jan 7, 2026
[8-K] GridAI Technologies Corp. Reports Material Event
Jan 8, 2026
[Form 4] GridAI Technologies Corp. Insider Trading Activity
Jan 13, 2026
[SCHEDULE 13G] GridAI Technologies Corp. Passive Investment Disclosure (>5%)
Nov 19, 2025
[10-Q] Entero Therapeutics, Inc. Quarterly Earnings Report
Nov 17, 2025
[NT 10-Q] Entero Therapeutics, Inc. SEC Filing

ENTO Stock Data

10.05M
3.25M
7.3%
2.56%
1.75%
Biotechnology
Pharmaceutical Preparations
Link
United States
BOCA RATON